New Opportunities for Improved Patient Outcomes in Graft-Versus-Host-Disease

New Opportunities for Improved Patient Outcomes in Graft-Versus-Host-Disease is organized by i3 Health and will be held from Aug 22, 2022 - Aug 21, 2023.,,Statement Of Need:,Graft-versus-host disease (GHVD) is a common complication of allogeneic hematopoietic stem cell transplant (HSCT) and a major contributor to morbidity and mortality (DeFilipp et al, 2021; Malard et al, 2020). Acute GVHD occurs within 100 days of transplant and typically targets the skin, gastrointestinal tract, and liver (LLS, 2022). Chronic GVHD often presents within the first year following HSCT but may develop in subsequent years. It most commonly affects the skin; however, involvement of other sites such as the liver, gastrointestinal tract, joints, fascia, and lungs can occur alone or concurrently (LLS, 2022). In recent years, advances in the management of other HSCT–related complications such as cytomegalovirus and invasive fungal infections have led to substantial reductions in mortality (Rahi et al, 2021). Despite intensive research, GVHD remains a challenge due to its heterogeneity and complex pathogenesis (Malard et al, 2020). In this podcast, Shernan Holtan, MD, of the University of Minnesota and Carrie Kitko, MD, of Vanderbilt University Medical Center will explore new biomarkers used for diagnosis and therapy selection, discuss the latest clinical trial findings, and advise practitioners on how to individualize treatment to patients’ needs.,,Learning Objectives:,Participants should be able, upon completion, to,• Appraise emerging insights into biomarkers for improved diagnosis and therapy selection in GVHD,• Assess recent clinical trial findings on the efficacy and safety of emerging therapies for acute and chronic GVHD,• Evaluate the implications of recent clinical advances in GVHD for supporting patients and meeting their individual care needs,Faculty:,• Shernan Holtan, MD (Chairperson),Associate Professor of Medicine,University of Minnesota,• Carrie Kitko, MD,Associate Professor of Pediatrics,Vanderbilt University Medical Center,Gain expert insight and enhance your clinical knowledge with this case-based activity focusing on new and groundbreaking biomarkers used for diagnosis of graft-versus-host disease, factors for therapy selection, and clinical trial findings used to individualized treatment for patents, presented by leading faculty Shernan Holtan, MD, Associate Professor of Medicine, University of Minnesota, and Carrie Kitko, MD, Associate Professor of Pediatrics, Vanderbilt University Medical Center. Start the activity now!